Blog

Investors looking for stocks in the Insurance - Multi line sector might want to consider either M?nchener R?ckversicherungs-Gesellschaft (MURGY) or Oscar Health, Inc. (OSCR). But which of these two

Investors with an interest in Chemical - Diversified stocks have likely encountered both LyondellBasell (LYB) and Albemarle (ALB). But which of these two stocks is more attractive to value

Reinsurance Group of America, Incorporated RGA reported first-quarter 2026 adjusted operating earnings of $6.97 per share, which beat the Zacks Consensus Estimate by 12.6%. The bottom line rose

NuScale Power SMR shares lost 5% on Thursday in the after-market hours after the company reported weaker-than-expected bottom-line results for the first quarter of 2026.

NuScale Power reported

Affirm Holdings, Inc. AFRM posted third-quarter fiscal 2026 earnings of 30 cents per share, which beat the Zacks Consensus Estimate by 76.5%. The metric rose from 1 cent a year ago.

Net revenues

Innodata Inc. INOD delivered first-quarter 2026 results with adjusted earnings per share (EPS) and revenues topping the Zacks Consensus Estimate, supported by strength in AI-related data services

Expedia Group EXPE reported first-quarter 2026 adjusted earnings of $1.96 per share, up 386% year over year, and surpassed the Zacks Consensus Estimate by 39.01%.Revenues rose 15% from the year-ago

Jabil, Inc. JBL is aggressively expanding manufacturing capabilities for AI servers, liquid cooling, silicon photonics and cloud infrastructure. The company is aiming to become a core infrastructure

Lamar Advertising Company LAMR posted first-quarter 2026 AFFO per share of $1.72, up 7.5% year over year and ahead of the Zacks Consensus Estimate of $1.57 by 9.6%. Quarterly net revenues of $528.0

Ford Motor Company F is focusing on software and services as it works toward its long-term profitability goals. The company expects its software and physical services business, currently generating

A month has gone by since the last earnings report for Constellation Brands (STZ). Shares have lost about 7.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend

A month has gone by since the last earnings report for RPM International (RPM). Shares have lost about 8.6% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue

A month has gone by since the last earnings report for Delta Air Lines (DAL). Shares have added about 7.8% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the

YPF Sociedad Anonima (YPF) reported $4.95 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 7.3%. EPS of $1.03 for the same period compares to $0.62 a

Embraer (EMBJ) reported $1.45 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 31.2%. EPS of $0.16 for the same period compares to $0.40 a year ago.

The

It has been about a month since the last earnings report for Applied Digital Corporation (APLD). Shares have added about 62.4% in that time frame, outperforming the S&P 500.

But investors have to be

Boston Scientific’s BSX Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. This segment reflects the company’s

Tesla TSLA received its largest-ever Tesla Semi order after WattEV announced plans to purchase 370 electric Class 8 trucks. The order is valued at about $100 million and is expected to become the

Gilead Sciences, Inc. GILD reported first-quarter 2026 adjusted earnings per share (EPS) of $2.03, which beat the Zacks Consensus Estimate of $1.89. In the year-ago quarter, the company reported an

The semiconductor industry has been on a strong upward trajectory since 2024, and that momentum has carried into 2026. Growing demand for artificial intelligence (AI) technologies has pushed major

MPLX LP MPLX reported first-quarter 2026 earnings of 90 cents per share, which missed the Zacks Consensus Estimate of $1.05 by 14.3%. The bottom line declined from the year-ago quarter’s level of

For the quarter ended March 2026, Amneal Pharmaceuticals (AMRX) reported revenue of $723 million, up 4% over the same period last year. EPS came in at $0.27, compared to $0.21 in the year-ago

Iovance Biotherapeutics IOVA incurred a first-quarter 2026 loss of 19 cents per share, in line with the Zacks Consensus Estimate. In the year-ago quarter, the company reported a loss of 36 cents.

Much as we saw in Wednesday’s private-sector payrolls from ADP (ADP), this morning’s Employment Situation report from the U.S. Bureau of Labor Statistics (BLS) was better than expected: +115K new

W&T Offshore, Inc. WTI posted break-even first-quarter 2026 earnings per share, compared with the Zacks Consensus Estimate of 2 cents. Revenues of $150.0 million beat the consensus mark of $137.0